- Home
- Companies
- EyeYon Medical Ltd
- Articles
EyeYon Medical Ltd articles
Abstract
This case report demonstrates the effectiveness of a combined unique soft contact lens design and hypertonic saline at reducing corneal edema symptoms. In addition, this case shows that using tomographic data is invaluable for detecting and monitoring of these presentations.
Nir Erdinest;Naomi ;Nadav Levingera
Abstract
The purpose of this study was to describe a novel device that may serve as an alternative to Descemet membrane endothelial keratoplasty (DMEK) for the treatment of chronic corneal edema.
Methods:The EndoArt (EyeYon Medical, Israel) is a flexible, 50-μm thin artificial endothelial layer that matches the cornea’s posterior curvature and functions as a fluid
Gerd U. Auffarth;Hyeck-Soo Son;Matthias Koch;Jan Weindler;Patrick Merz;Ofer Daphna;Arie L. Marcovich;Victor A. Augustin
Abstract
Introduction. To compare the safety and efficacy of the Therapeutic Hyper-CL™ lens versus a standard bandage contact lens (PureVision B&L) for chronic corneal edema.
Methods. Prospective, multicenter, randomized, crossover study. Chronic corneal edema patients were randomized to one of two arms. The first arm was fitted with the Therapeutic Hyper-CL™ lens while the second arm was fitted with a standard soft b
Ofer Daphna;Michael Mimouni;Yariv Keshet;Meydan Ben Ishai;Irina S. Barequet;Boris Knyazer;Ewa Mrukwa-Kominek;Tomasz Zarnowski;Malca Chen-Zion;Arie Marcovich
The first in-human trials of a novel artificial implant designed to replace dysfunctional corneal endothelium have shown the device to be safe and well-tolerated, according to a study presented at the 25th ESCRS Winter Meeting online.“The initial results of the EndoArt (EyeYon Medical) are very promising indeed,” said Ruth Lapid-Gortzak MD, PhD, Amsterdam University Medical Centre in the Netherlands.
“There were no device-related adverse events over the 12 months&rsq
Dermot McGrath;Ruth Lapid-Gortzak
NESS ZIONA, Israel, Feb. 5, 2020 /PRNewswire/ -- EyeYon Medical (https://eye-yon.com/) is a start-up company developing a variety of ophthalmic products for vision-threatening conditions. EyeYon`s new product, now on an accelerated path as a Breakthrough Device, is an Artificial Endothelial Layer - EndoArt® - a polymer film implant, attached to the posterior corneal surface, to treat chronic corneal edema secon